TCL Archive Moertel Criticizes Janssen Over Levamisole Price, Delivers Final Report On Intergroup Adjuvant Trial June 12, 1992
TCL Archive FDA Approved More Than 50 New Indications For Cancer In 32 Months, Analysis Finds February 19, 2010
TCL Archive NCAB Asks For Cost Reimbursement n Patients In Clinical Trials Until More Data Available October 5, 1984
TCL Archive Prognostic Factors Don’t Explain Better Prostate Cancer Survival In Most Asian Men August 31, 2007